Beta Thalassemia Major
📧 Sign up to get email alerts when something new happens for Beta Thalassemia Major.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-12-11FDA Approved: DEFERIPRONE — Original Application (DR. REDDY'S LABORATORIES, INC.)
FDA approved Dr. Reddy's Laboratories' original application for deferiprone, a generic iron chelator, enabling its marketing in the United S…
-
FDA approval · 2025-09-08FDA Approved: DEFERASIROX — Original Application (Aurobindo Pharma Limited)
The FDA approved an original ANDA for deferasirox (generic) manufactured by Aurobindo Pharma Limited, expanding access to iron chelation the…
-
FDA approval · 2025-08-15FDA Approved: DEFERIPRONE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Deferiprone submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2025-05-08FDA Approved: DEFEROXAMINE MESYLATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Deferoxamine Mesylate (Hospira, Inc.), a generic iron chelator.
-
FDA approval · 2025-03-26FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for Ferriprox (deferiprone) filed by Chiesi USA, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-26FDA Approved: DEFERASIROX — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for Deferasirox submitted by Amneal Pharmaceuticals NY LLC. The supplemental filing updates the …
-
FDA approval · 2023-11-14FDA Approved: DEFERASIROX — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for deferasirox submitted by Sun Pharmaceutical Industries, Inc., approving changes to the product l…
-
FDA approval · 2023-03-16FDA Approved: DEFERASIROX — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Deferasirox from Camber Pharmaceuticals, authorizing a generic product under ANDA 216229.
-
FDA approval · 2021-11-30FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for Ferriprox (deferiprone) filed by Chiesi USA, Inc.
-
FDA approval · 2021-04-30FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for Ferriprox (deferiprone) from Chiesi USA, Inc., signaling an approved modification to its exi…
-
FDA approval · 2021-04-30FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for Ferriprox (deferiprone) from Chiesi USA, Inc., indicating an approved change to the product’s la…
-
FDA approval · 2021-03-17FDA Approved: DEFERASOROX — Original Application (Novadoz Pharmaceuticals LLC)
The FDA granted approval for the original ANDA application of Deferasorox (deferasirox) by Novadoz Pharmaceuticals LLC as a generic product.…
-
FDA approval · 2020-06-16FDA Approved: DEFERASIROX — Original Application (Dr. Reddy's Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' deferasirox generic under ANDA210945 for the treatment of chronic iron overload due to blood transfus…
-
FDA approval · 2020-06-15FDA Approved: DEFERASIROX — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal's generic deferasirox (Deferasirox) as an original ANDA for the treatment of transfusion-related iron overload in pa…
-
FDA approval · 2020-05-19FDA Approved: FERRIPROX — Original Application (Chiesi USA, Inc.)
FDA approved Ferriprox (deferiprone) through the original NDA submitted by Chiesi USA, Inc.
-
FDA approval · 2019-12-30FDA Approved: DEFERASIROX — Original Application (Xiromed, LLC)
FDA approved Xiromed, LLC's generic deferasirox (DEFERASIROX) through an original ANDA.
-
FDA approval · 2019-05-24FDA Approved: EXJADE — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Exjade (deferasirox) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2019-02-08FDA Approved: DEFERIPRONE — Original Application (Sun Pharmaceutical Industries, Inc.)
Sun Pharmaceutical Industries received FDA approval for Deferiprone via original ANDA for the iron chelator used to treat iron overload in t…
-
FDA approval · 2018-05-11FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for JADENU (deferasirox) from Novartis Pharmaceuticals Corporation, expanding its labeling for iron …
-
FDA approval · 2018-04-20FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for Ferriprox (deferiprone) filed by Chiesi USA, Inc., resulting in updated labeling for iron ch…
-
FDA approval · 2017-05-18FDA Approved: JADENU — Original Application (Novartis Pharmaceuticals Corporation)
The FDA approved Jadenu (deferasirox) from Novartis as an oral iron chelator for chronic iron overload due to blood transfusions. This is th…
-
FDA approval · 2012-11-15FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for Ferriprox (deferiprone) filed by Chiesi USA, Inc., to modify/expand the product’s labeling.
-
CLINICAL_TRIALS approval · 2012-02-09Clinical Trial Update: Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Deferiprone has received approval for marketing to treat iron overload in patients with thalassemia and iron-induced heart disease.
-
FDA approval · 2011-10-14FDA Approved: FERRIPROX — Original Application (Chiesi USA, Inc.)
Ferriprox (deferiprone) has been approved by the FDA under an original application from Chiesi USA, Inc. for the treatment of iron overload …
-
FDA approval · 2007-04-20FDA Approved: EXJADE — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for EXJADE (deferasirox) submitted by Novartis Pharmaceuticals Corporation, resulting in an approved…